NCT00505180

Brief Summary

The purpose of this study is to prospectively identify blood markers that identify chronic hemodialysis patients at risk for early (\<90 days) and late (\>= 1 year) mortality

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,018

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2004

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2004

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2006

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 19, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 23, 2007

Completed
Last Updated

July 23, 2007

Status Verified

July 1, 2007

First QC Date

July 19, 2007

Last Update Submit

July 19, 2007

Conditions

End Stage Renal Disease

Keywords

HemodialysisMortality

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • End stage renal disease on hemodialysis at Fresenius Medical Center
  • New initiation of hemodialysis

You may not qualify if:

  • Death with 14 days of initiation of hemodialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ravi I Thadhani, MD, MPH

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 19, 2007

First Posted

July 23, 2007

Study Start

June 1, 2004

Study Completion

June 1, 2006

Last Updated

July 23, 2007

Record last verified: 2007-07